Human immunodeficiency virus-induced uveitis: intraocular and plasma human immunodeficiency virus-1 RNA loads. 2008

Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
Department of Ophthalmology, University Medical Center Utrecht, Utrecht, The Netherlands.

OBJECTIVE To report on a human immunodeficiency virus (HIV)-infected patient with uveitis and an intraocular HIV1 RNA load largely exceeding that of plasma and no evidence of other intraocular infectious agents causing uveitis than HIV itself. METHODS Interventional case report. METHODS A 37-year-old male HIV-infected patient with uveitis and no retinal manifestations. METHODS Clinical and laboratory examinations including extensive intraocular fluid analyses for various pathogens and HIV-1 RNA loads in the aqueous and plasma. METHODS Results of aqueous analysis and ophthalmologic features. Correlations between the results of aqueous testing and clinical characteristics. RESULTS A 37-year-old patient presented with progressive uveitis. He was positive for HIV-1, and his HIV-1 RNA plasma load was 44,600 copies/mL. His intraocular HIV-1 RNA load was >1,900,000 copies/mL, which largely exceeded his concurrent plasma load. No evidence of infectious agents other than HIV itself was found, and the uveitis reacted promptly to solely the antiretroviral treatment. CONCLUSIONS Our findings suggest that HIV can locally replicate within the eye and cause an intraocular inflammatory reaction.

UI MeSH Term Description Entries
D008297 Male Males
D003521 Cyclopropanes Three-carbon cycloparaffin cyclopropane (the structural formula (CH2)3) and its derivatives.
D003841 Deoxycytidine A nucleoside component of DNA composed of CYTOSINE and DEOXYRIBOSE. Cytosine Deoxyribonucleoside,Cytosine Deoxyriboside,Deoxyribonucleoside, Cytosine,Deoxyriboside, Cytosine
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000068679 Emtricitabine A deoxycytidine analog and REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B viruses. It is used to treat HIV INFECTIONS. Beta-L-2',3'-dideoxy-5-fluoro-3'-thiacytidine,Coviracil,Emtriva,Beta L 2',3' dideoxy 5 fluoro 3' thiacytidine
D000068698 Tenofovir An adenine analog REVERSE TRANSCRIPTASE INHIBITOR with antiviral activity against HIV-1 and HEPATITIS B. It is used to treat HIV INFECTIONS and CHRONIC HEPATITIS B, in combination with other ANTIVIRAL AGENTS, due to the emergence of ANTIVIRAL DRUG RESISTANCE when it is used alone. (R)-9-(2-phosphonylmethoxypropyl)adenine,9-(2-Phosphonomethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine,9-(2-Phosphonylmethoxypropyl)adenine, (+-)-isomer,9-(2-Phosphonylmethoxypropyl)adenine, (R)-isomer - T357098,9-(2-Phosphonylmethoxypropyl)adenine, (S)-isomer,9-PMPA (tenofovir),Tenofovir Disoproxil,Tenofovir Disoproxil Fumarate,Viread,Disoproxil Fumarate, Tenofovir,Disoproxil, Tenofovir,Fumarate, Tenofovir Disoproxil
D000225 Adenine A purine base and a fundamental unit of ADENINE NUCLEOTIDES. Vitamin B 4,4, Vitamin B,B 4, Vitamin
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000480 Alkynes Hydrocarbons with at least one triple bond in the linear portion, of the general formula Cn-H2n-2. Acetylenic Compounds,Alkyne,Acetylenes

Related Publications

Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
January 2011, AIDS (London, England),
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
February 2023, Viruses,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
July 2012, Ophthalmology,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
May 1998, The Journal of infectious diseases,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
February 2001, The Journal of infectious diseases,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
November 2000, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
January 1991, Journal francais d'ophtalmologie,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
February 2010, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
September 1994, The Journal of infectious diseases,
Aniki Rothova, and Margriet Schneider, and Jolanda D F de Groot-Mijnes
May 2001, The Journal of infectious diseases,
Copied contents to your clipboard!